AMN Healthcare Services Inc (NYSE: AMN), a prominent name in the healthcare sector, is catching the eye of investors with a potential upside of 3.24%. Despite the challenges reflected in..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a healthcare company based in San Diego, California, specializing in biotechnology. With a market cap of $874.85 million, Maravai LifeSciences plays a pivotal..
Delcath Systems, Inc. (NASDAQ: DCTH) is drawing significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $364.16 million, this New York-based interventional..
Nurix Therapeutics, Inc. (NRIX), a burgeoning player in the biotechnology industry, presents a compelling case for investors eyeing high-growth opportunities in the healthcare sector. Based in San Francisco, this clinical-stage..
Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, has captured the attention of investors with an eye-popping potential upside of 302.40%. With a market capitalization of $608.45 million, this..
Immunome, Inc. (NASDAQ: IMNM) is making waves in the biotechnology sector, offering exciting prospects for investors looking to capitalize on its burgeoning pipeline of cancer therapies. With a market cap..
InnovAge Holding Corp. (NASDAQ: INNV) stands out in the healthcare sector as a unique player focusing on the needs of seniors through its PACE (Program of All-Inclusive Care for the..
Neuropace, Inc. (NASDAQ: NPCE) is capturing attention in the healthcare sector, particularly within the medical devices industry, as its innovative solutions target a critical unmet need in epilepsy treatment. With..
Investors with an eye on the healthcare sector may find Niagen Bioscience, Inc. (NASDAQ: NAGE) a compelling opportunity. With a market capitalization of $779.19 million and a focus on developing..
For individual investors with an appetite for high-risk, high-reward stocks, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) offers a tantalizing opportunity. With a potential upside of over 110%, according to analyst ratings,..
Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, primarily focuses on the production and distribution of animal health and mineral nutrition products. With a market..
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing investor attention with a staggering potential upside of 221.22%, as analysts remain bullish on this clinical-stage biotechnology firm. Focused on addressing unmet needs..
Investors with a keen eye on the biotechnology sector might want to turn their attention to AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotech firm making waves in the healthcare..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector with its ambitious approach to developing breakthrough treatments for both pediatric and adult diseases. As a commercial-stage..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a Boston-based biotechnology company, is garnering attention in the healthcare sector for its innovative approach to treating central nervous system (CNS) disorders. Despite the..
For investors navigating the vast terrain of healthcare stocks, Fulgent Genetics, Inc. (NASDAQ: FLGT) presents an intriguing case with a potential upside of 18.41%, according to recent analyst ratings. As..
Arcus Biosciences, Inc. (NASDAQ: RCUS), a burgeoning name in the biotechnology sector, offers an intriguing proposition for investors with its potential 170.65% upside. This clinical-stage biopharmaceutical company, dedicated to developing..
Investors with an eye on the biotechnology sector might want to focus on LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising biopharmaceutical company dedicated to developing innovative therapies aimed at improving..
AnaptysBio, Inc. (NASDAQ: ANAB) presents a compelling opportunity for investors with a significant potential upside of 123.48%. As a clinical-stage biotechnology company focused on innovative immunology therapeutics, AnaptysBio’s pipeline and..
Nuvation Bio Inc. (NASDAQ: NUVB), a burgeoning player in the biopharmaceutical landscape, is capturing the attention of investors with a noteworthy potential upside of 173.72%. This clinical-stage biotech firm, with..
